Recurrent IgA Nephropathy After Kidney Transplantation.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Large numbers of patients with end-stage kidney disease caused by IgA nephropathy are transplanted every year, and each of these patients faces the risk of recurrence in their kidney graft. We review the epidemiology, diagnosis, and outcomes of recurrent IgA nephropathy. Mechanistic insights, therapeutic options, and knowledge gaps are reviewed, and we discuss future options to better understand and manage this disorder.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Transplantation

Title: Transplantation

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1534-6080

ISSN (Print): 0041-1337

Publication date (Electronic): Sep 2016

Volume: 100

Issue: 9

Affiliations

[1 ] 1 Department of Renal Medicine and Transplantation, Royal Prince Alfred Hospital, Sydney, Australia. 2 Kidney Node, Charles Perkins Centre, Sydney Medical School, University of Sydney, Sydney, Australia. 3 Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Adelaide, Australia.

Article

DOI: 10.1097/TP.0000000000001093

PubMed ID: 26895219

SO-VID: 2020d894-66e9-4063-9218-ea9b6c704fca

History

Data availability:

Comments

Comment on this article

scite_

Cited by 18

See all cited by